RYVAX | VGELX | RYVAX / VGELX | |
Total Expense Ratio | 1.65 | 0.37 | 446% |
Annual Report Gross Expense Ratio | 1.68 | 0.37 | 454% |
Fund Existence | 27 years | 24 years | - |
Gain YTD | -16.728 | 12.492 | -134% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 50000 | 5% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.35M | 5.92B | 0% |
Annual Yield % from dividends | 0.00 | 3.21 | - |
Returns for 1 year | -23.47 | -3.75 | 626% |
Returns for 3 years | -0.52 | 6.43 | -8% |
Returns for 5 years | 51.87 | 43.57 | 119% |
Returns for 10 years | -62.41 | 3.85 | -1,622% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
OAKWX | 25.56 | 0.07 | +0.27% |
Oakmark Global Select Investor | |||
GFBLX | 40.45 | -0.01 | -0.02% |
American Funds Global Balanced F3 | |||
TPLGX | 81.89 | -0.07 | -0.09% |
T. Rowe Price Instl Large Cap Core Gr | |||
VDSIX | 24.69 | -0.11 | -0.44% |
Victory Diversified Stock I | |||
TSLIX | 5.14 | -0.03 | -0.58% |
Transamerica Small Cap Value I |